Antidepressant drug induced alterations in binding to central dopamine transporter sites in the Wistar Kyoto rat strain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 1, 2006, Pages 30-41

  Jiao, Xilu ^a   Paré, William P ^b   Tejani Butt, Shanaz M ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bupropion; Depression; Dopamine transporter; Nomifensine; Wistar Kyoto rat

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DOPAMINE TRANSPORTER; NOMIFENSINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN REGION; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG MECHANISM; MALE; NONHUMAN; OPEN FIELD TEST; RAT; RAT STRAIN; STRAIN DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BINDING SITES; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG INTERACTIONS; MALE; PIPERAZINES; RADIOLIGAND ASSAY; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REACTION TIME; SPECIES SPECIFICITY; TRITIUM;

EID: 29644432910     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.06.017     Document Type: Article

References (55)

1. G.R. Athey, and S.G. Iams Cold-restrain induced gastric lesions in normotensive and spontaneously hypertensive rats Life Sci. 28 1981 889 894
2. N. Bonhomme, and E. Esposito Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review J. Clin. Psychopharmacol. 18 1998 447 454
3. 3H] mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR 12783 or cocaine J. Pharmacol. Exp. Ther. 278 1996 330 337
4. B.R. Cooper, T.J. Hester, and R.A. Maxwell Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo J. Pharmacol. Exp. Ther. 215 1980 127 134
5. R. De La Garza II, and J.J. Mahoney III A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression Brain Res. 1021 2004 209 218
6. G. Di Chiara, P. Loddo, and G. Tanda Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression Biol. Psychiatry 46 1999 1624 1633
7. G. Drolet, K. Proulx, D. Pearson, J. Rochford, and C.F. Deschepper Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains Neuropsychopharmacology 27 2002 400 409
8. J.P. Feighner The new generation of antidepressants J. Clin. Psychiatry 44 1983 49 55
9. S. Fielding, and M. Szewczak Pharmacology of nomifensine: a review of animal studies J. Clin. Psychiatry 45 1984 12 20
10. A. Frazer Antidepressants J. Clin. Psychiatry 58 Suppl. 6 1997 9 25
11. R.N. Golden, L. DeVane, S.C. Laizure, M.V. Rudorfer, M.A. Sherer, and W.Z. Potter Bupropion in depression: II. The role of metabolites in clinical outcome Arch. Gen. Psychiatry 45 1988 145 149
12. G. Griebel, C. Cohen, G. Perrault, and D.J. Sanger Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats Physiol. Behav. 67 1999 315 320
13. P. Grot, B. Saxena, L. Daigle, and G. Mahutte Dopaminergic agonist nomifensine compared with amitriptyline: a double-blind clinical trial in acute primary depressions Br. J. Clin. Pharmacol. 4 1977 221s 225s
14. C. Gustafson Brain Software for Autoradiography, Version 3.0 1995
15. 3H] mazindol binding sites in rat striatum by dopaminergic agents Eur. J. Pharmacol. 250 1993 261 266
16. X. Jiao, W.P. Paré, and S.M. Tejani-Butt Strain differences in the distribution of dopamine transporter sites in rat brain Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 913 919
17. S. Kapur, and J.J. Mann Role of the dopaminergic system in depression Biol. Psychiatry 32 1992 1 17
18. K. Kobayashi, and H. Sano Dopamine deficiency in mice Brain Dev. 22 2000 S54 S60
19. M.J. Kuhar Recent biochemical studies of the dopamine transporter-a CNS drug target Life Sci. 62 1998 1573 1575
20. A. Lahmame, C. del Arco, A. Pazos, M. Yritia, and A. Amario Are Wistar-Kyoto rats a genetic model of depression resistant to antidepressants? Eur. J. Pharmacol. 337 1997 115 123
21. C. Lopez-Rubalcava, and I. Lucki Strain differences in the behavioral effects of antidepressant drugs in the Forced Swim Test Neuropsychopharmacology 22 2000 191 199
22. A. Markou, T.R. Kosten, and G.F. Koob Neurobiological similarities in Depression and drug dependence: a self-medication hypothesis Neuropsychopharmacology 18 1998 135 174
23. 2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments Pharmacol. Biochem. Behav. 51 1995 565 569
24. J.A. Morón, A. Brockington, R.A. Wise, B.A. Rocha, and B.T. Hope Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines J. Neurosci. 22 2002 389 395
25. O.V. Mortensen, and S.G. Amara Dynamic regulation of the dopamine transporter Eur. J. Pharmacol. 479 2003 159 170
26. N. Nakachi, Y. Kiuchi, M. Inagaki, M. Inazu, Y. Yamazaki, and K. Oguchi Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats Eur. J. Pharmacol. 281 1995 195 203
27. W.P. Paré "Behavioral despair" test predicts ulceration in WKY rats Physiol. Behav. 46 1989 993 998
28. W.P. Paré Learning behavior, escape behavior, and depression in an ulcer susceptible rat strain Integr. Physiol. Behav. Sci. 27 1992 130 141
29. W.P. Paré Hyponeophagia in Wistar Kyoto rats Physiol. Behav. 55 1994 975 978
30. W.P. Paré, and S.M. Tejani-Butt Effect of stress on the behavior and 5-HT system in Sprague Dawley and Wistar Kyoto rat strains Integr. Physiol. Behav. Sci. 31 1996 112 121
31. W.P. Paré, S.M. Tejani-Butt, and J. Kluczynski Strain differences in the open field test and the Porsolt forced swim test following antidepressant treatment Neuroscience 26 2000 (Abstract 387.20)
32. W.P. Paré, S.M. Tejani-Butt, and J. Kluczynski The emergence test: effects of psychotropic drugs on neophobic disposition in Wistar Kyoto (WKY) and Sprague Dawley rats Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 2001 1615 1628
33. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press New York
34. E.C. Petrie, R.C. Veith, and P. Szot Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22 1998 845 856
35. C.J. Pycock, I.M. Donaldson, and C.D. Marsden Circling behavior produced by unilateral lesions in the region of the locus coeruleus in rats Brain Res. 97 1975 317 329
36. S. Rahman, E. Engleman, J. Simon, and W.J. McBride Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens Eur. J. Pharmacol. 414 2001 37 44
37. A. Randrup, I. Munkvad, and R. Fog Mania, depression and brain dopamine W.B. Essman L. Valzellli Current Developments in Psychopharmacology 1975 Spectrum Publications New York 207 229
38. E. Redei, W.P. Paré, F. Aird, and J. Kluczynski Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer Am. J. Physiol. 266 1994 R353 R360
39. M.E.A. Reith, C. Xu, and N.H. Chen Pharmacology and regulation of the neuronal dopamine transporter Eur. J. Pharmacol. 324 1997 1 10
40. E. Rolls The Brain and Emotion 1999 Oxford University Press Oxford Chapter 6
41. R.H. Roth, and J.D. Elsworth Biochemical pharmacology of midbrain dopamine neurons F.E. Bloom D.J. Kupfer Psychopharmacology: The Fourth Generation of Progress 1995 Raven New York 227 243
42. E.C. Settle Bupropion: a novel antidepressant-update 1989 Int. Drug Ther. Newsl. 24 1989 29 36
43. G.P. Smith, and L.H. Schneider Relationships between mesolimbic dopamine function and eating behavior P.W. Kalivas C.B. Nemeroff The Mesocorticolimbic Dopamine System Ann. N. Y. Acad. Sci. vol. 537 1988 254 261
44. S.M. Stahl Basic psychopharmacology of antidepressant: Part I. Antidepressants have seven distinct mechanisms of action J. Clin. Psychiatry 59 Suppl. 4 1998 S5 S14
45. R.F. Suckow, T.M. Smith, A.S. Perumal, and T.B. Cooper Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs Drug Metab. Dispos. 14 1986 692 697
46. S.M. Tejani-Butt, W.P. Paré, and J. Yang Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats Brain Res. 649 1994 27 35
47. S.M. Tejani-Butt, J. Kluczynski, and W.P. Paré Strain dependent modification of behavior following antidepressant treatment Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 7 14
48. S.R. Tella, B. Ladenheim, and J.L. Cadet Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine J. Pharmacol. Exp. Ther. 281 1997 508 513
49. T. Vander Borght, M. Kilbourn, T. Desmond, D. Kuhl, and K. Frey The vesicular monoamine transporter is not regulated by dopaminergic drug treatments Eur. J. Pharmacol. 294 1995 577 583
50. H.M. van Praag, G.M. Asnis, R.S. Kahn, S.L. Brown, M. Korn, J.M. Harkavy Frieclman, and S. Wetzler Monoamines and abnormal behavior: a multi-aminergic perspective Br. J. Psychiatry 157 1990 723 734
51. H.K. Wayment, J.O. Schenk, and B.A. Sorg Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition J. Neurosci. 21 2001 35 44
52. C.C. Will, F. Aird, and E.E. Redei Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants Mol. Psychiatry 8 2003 925 932
53. P. Willner Dopamine and depression: a review of recent evidence: II. Theoretical approaches Brain Res. 287 1983 225 236
54. P. Willner The mesolimbic dopamine system as a target for rapid antidepressant action Int. Clin. Psychopharmacol. 12 Suppl. 3 1997 7 14
55. Y. Wu, S.M. Pearl, M.J. Zigmond, and A.C. Michael Inhibitory glutamatergic regulation of evoked dopamine release in striatum Neuroscience 96 2000 65 72